VKTX icon

Viking Therapeutics
VKTX

Overview Fund Trends Analyst Outlook Journalist POV

18 hedge funds and large institutions have $3.85M invested in Viking Therapeutics in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

1.63% more ownership

Funds ownership: 5.67% → 7.3% (+1.6%)

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$932K
2
+$554K
3
+$198K
4
Citadel Advisors
Citadel Advisors
Florida
+$108K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$98K

Top Sellers

1
-$525K
2
-$18K
3
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$932K
2
$769K
3
$647K
4
$554K
5
$382K
6
$136K
7
$108K
8
$98K
9
$70K
10
$59K
11
$32K
12
$22K
13
$20K
14
$19K
15
$2K
16
$1K
17
$1K
18
–
19
–